- Home
- PLAY vs SION Comparison
PLAY vs SION Comparison
Compare PLAY & SION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLAY
- SION
- Stock Information
- Founded
- PLAY 1982
- SION 2019
- Country
- PLAY United States
- SION United States
- Employees
- PLAY N/A
- SION N/A
- Industry
- PLAY Restaurants
- SION
- Sector
- PLAY Consumer Discretionary
- SION
- Exchange
- PLAY Nasdaq
- SION NYSE
- Market Cap
- PLAY 678.9M
- SION 564.4M
- IPO Year
- PLAY 1995
- SION 2025
- Fundamental
- Price
- PLAY $23.86
- SION $17.22
- Analyst Decision
- PLAY Buy
- SION Strong Buy
- Analyst Count
- PLAY 6
- SION 1
- Target Price
- PLAY $27.25
- SION $32.00
- AVG Volume (30 Days)
- PLAY 940.3K
- SION 142.5K
- Earning Date
- PLAY 06-10-2025
- SION 05-12-2025
- Dividend Yield
- PLAY N/A
- SION N/A
- EPS Growth
- PLAY N/A
- SION N/A
- EPS
- PLAY 1.46
- SION N/A
- Revenue
- PLAY $2,132,700,000.00
- SION N/A
- Revenue This Year
- PLAY $3.48
- SION N/A
- Revenue Next Year
- PLAY $5.75
- SION N/A
- P/E Ratio
- PLAY $16.16
- SION N/A
- Revenue Growth
- PLAY N/A
- SION N/A
- 52 Week Low
- PLAY $15.08
- SION $7.26
- 52 Week High
- PLAY $51.30
- SION $25.19
- Technical
- Relative Strength Index (RSI)
- PLAY 62.28
- SION N/A
- Support Level
- PLAY $20.75
- SION N/A
- Resistance Level
- PLAY $23.85
- SION N/A
- Average True Range (ATR)
- PLAY 1.21
- SION 0.00
- MACD
- PLAY 0.13
- SION 0.00
- Stochastic Oscillator
- PLAY 98.27
- SION 0.00
About PLAY Dave & Buster's Entertainment Inc.
Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.
About SION SIONNA THERAPEUTICS INC
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.